Medical Developments International Limited
MDDVF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $39,056 | $33,149 | $32,337 | $21,943 |
| % Growth | 17.8% | 2.5% | 47.4% | – |
| Cost of Goods Sold | $9,629 | $8,783 | $34,853 | $25,003 |
| Gross Profit | $29,427 | $24,366 | -$2,516 | -$3,060 |
| % Margin | 75.3% | 73.5% | -7.8% | -13.9% |
| R&D Expenses | $271 | $313 | $236 | $220 |
| G&A Expenses | $22,139 | $32,545 | $32,578 | $22,212 |
| SG&A Expenses | $26,083 | $35,367 | $36,403 | $24,808 |
| Sales & Mktg Exp. | $3,944 | $2,822 | $3,825 | $2,596 |
| Other Operating Expenses | $0 | -$275 | -$18,882 | -$12,393 |
| Operating Expenses | $26,354 | $35,405 | $17,757 | $12,635 |
| Operating Income | $3,073 | -$11,039 | -$14,427 | -$15,695 |
| % Margin | 7.9% | -33.3% | -44.6% | -71.5% |
| Other Income/Exp. Net | -$2,905 | -$21,887 | $0 | -$213 |
| Pre-Tax Income | $168 | -$32,926 | -$7,492 | -$15,908 |
| Tax Expense | $74 | $8,066 | -$1,883 | -$3,501 |
| Net Income | $94 | -$40,992 | -$5,609 | -$12,407 |
| % Margin | 0.2% | -123.7% | -17.3% | -56.5% |
| EPS | 0.001 | -0.47 | -0.067 | -0.17 |
| % Growth | 100.2% | -605.7% | 60.8% | – |
| EPS Diluted | 0.001 | -0.47 | -0.067 | -0.17 |
| Weighted Avg Shares Out | 117,500 | 86,299 | 84,274 | 72,427 |
| Weighted Avg Shares Out Dil | 112,157 | 86,305 | 84,274 | 72,427 |
| Supplemental Information | – | – | – | – |
| Interest Income | $302 | $402 | $657 | $45 |
| Interest Expense | $0 | $86 | $95 | $103 |
| Depreciation & Amortization | $1,533 | $3,394 | $3,113 | $2,945 |
| EBITDA | $1,674 | -$29,446 | -$4,284 | -$12,860 |
| % Margin | 4.3% | -88.8% | -13.2% | -58.6% |